This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02449/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02449/identifier/pubchem-compound/
n11http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB02449/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB02449/identifier/drugbank/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02449
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB02449 n11:DB02449
dcterms:title
3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid
adms:identifier
n4:5288108 n7:DB02449 n12:46506875 n13:DPS
n5:IUPAC-Name
n6:271B5EFE-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5F04-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5F03-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5F00-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5F01-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5F02-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5EFC-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5EFA-363D-11E5-9242-09173F13E4C5 n6:271B5EFD-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5EFB-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5F0A-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5F0B-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5F05-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5F06-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5F08-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5F07-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5F09-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5F10-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5F12-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5F13-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5F0F-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5F0E-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5F11-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5EFF-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5F0C-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5F0D-363D-11E5-9242-09173F13E4C5